11 Billion Euro Cut BASF Slashes 2025 Outlook as Q2 Earnings Plunge and Strategic Moves Accelerate
BASF reported Q2 2025 sales of €15.77 billion, down 2.1% year-on-year amid falling prices and negative currency effects across all divisions, especially chemicals. The company’s EBITDA before special items fell 9.7% to €1.77 billion, while EBIT dropped 5.8% to €490 million. Net income plunged 81.4% to just €80 million, compared to €430 million a year ago.
Citing ongoing macroeconomic and geopolitical uncertainty, BASF has sharply revised its 2025 EBITDA guidance to €7.3–7.7 billion, up to €1.1 billion lower than its previous forecast. The main pressure: persistent margin compression in upstream products and ample market supply.
Despite the downturn, BASF accelerated two major strategic projects:
The company has completed the acquisition of Domo’s 49% stake in Alsachimie, giving BASF full ownership of the Chalampé PA6,6 intermediate plant in France. This move strengthens BASF’s backward integration, supply security, and value chain efficiency in polyamide 6,6.
Meanwhile, BASF finalized the sale of its Styrodur® XPS insulation business—along with the brand—to BACHL, a leading German insulation producer and long-term BASF partner. This shift allows BASF to focus on its EPS brands, Neopor® and Styropor®, with plans to boost Neopor® capacity in Ludwigshafen by 50,000 tons to 250,000 tpa by 2027.
These moves signal BASF’s determination to optimize its portfolio and reinforce its position across key segments, even as it weathers a tough business climate.
2026-08-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Symrise Opens New Production Unit in Granada to Ensure Safer Supply of Bio-Based Pentylene Glycol
-
Mitsubishi Gas Chemical Suspends Construction of MXDA Plant in the Netherlands
-
NHU and Sinopec Advance Liquid Methionine Project
-
BASF and Nihon Nohyaku Partner for Fruit Crop Protection in Japan
-
Doré Partners with Evolved By Nature to Launch Two Breakthrough Skincare Products
-
When the Chemical Industry Is No Longer Highly Profitable: Sinochem International’s 2.4 Billion Yuan Loss Reveals the Truth About Industry Cycles
-
AstraZeneca Targets Year-End Filing for Novel Hypertension Drug Baxdrostat
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
Avery Dennison to Acquire Meridian’s Flooring Adhesives Business for $390 Million
-
Aurobindo Pharma’s $145 Million China Plant Set to Break Even by Q3 FY26 Global Expansion Gains Speed
Recommend Reading
-
South Korea Moves Urgently to Control Petrochemical Feedstock Hoarding as Supply Chain Risk Escalates to the National Security Level
-
LyondellBasell Expands Laboratory Capabilities at Suzhou Technology Center
-
Wanhua Chemical Is Fighting Counterfeits While Raising Prices
-
Lier Chemical Gains Momentum as Chlorantraniliprole Supply Stabilizes
-
BASF Commits to Safeguarding Jobs at the Ludwigshafen Site Through 2028 with Multi-Billion-Euro Investments
-
From January to August 2025, China's cumulative production of bisphenol A reached 3,150,000 tons
-
Supply Disruptions of Lithium Carbonate Dominate Expectations, Oscillating Pattern Hard to Change
-
Thymol Gel Wins EPA Approval for Beekeepers
-
Weak Supply and Demand Weigh Down Melamine Market Sentiment
-
Since the beginning of the year, the EVA market in China has seen a significant increase; indicators from Business Society suggest cautious short-term operations
- Hot Searches
- soy protein supplier
- bioglutide peptide for sale
- aluminum perchlorate
- where to get retatrutide
- food grade antifoams and defoamers
- methyl acrylate sds
- compound retatrutide
- fluocinolone acetonide oil ear drops 0.01 price
- sodium dichloroisocyanurate
- hobt sds
- bioglutide for sale
- acrylonitrile butadiene styrene price